Danish food ingredients firm Danisco has announced that it has agreed to buy all the outstanding shares it does not already own in US-based biotechnology company Genencor.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more


Danisco said the total acquisition price is DKK2.4bn (US$419m) and completion of the deal is expected no later than 31 May 2005. Following completion, Genencor will be a wholly owned subsidiary of Danisco.


Danisco CEO Alf Duch-Pedersen said the acquisition of Genencor will enhance Danisco’s capabilities in enzymes for food and feed.


“Being an advanced and recognised biotech business, Genencor will expand our knowledge base significantly and broaden our access to a new important business area, industrial enzymes,” he added.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Just Food Excellence Awards - Nominations Closed

Nominations are now closed for the Just Food Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Winning five categories in the 2025 Just Food Excellence Awards, Centric Software is setting the pace for digital transformation in food and FMCG. Explore how its integrated PLM and PXM suite delivers faster launches, smarter compliance and data-driven growth for complex, multi-channel product portfolios.

Discover the Impact